Leaders at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) recognized that in recent years, a large proportion of National Institutes of Health (NIH) funded clinical trials have not achieved target enrollment within the allotted time or budget, and some have been terminated early for futility.¹ Based on a retrospective review of National Heart, Lung, and Blood Institute (NHLBI) funded trials, only 26% were successfully defined as achieving 100 percent enrollment in the target time allowed.
This webinar explored the perspectives and occasional conflicting interests of both parties, fostering mutual understanding. Representatives from each organization shared insights, real-life examples, and practical tools to overcome challenges, promoted productive collaboration, and contributed to clinical trial success
In this webinar, expert panelists discussed how sponsors can smooth the LGBTQIA+ patient journey for clinical trials, starting with gender-neutral protocols, making trial communication more inclusive, the FDA’s draft guidance on diversity plans and data collection, and the roles that sites/investigators can play.
Discover the exciting world of clinical research at Merck during this informative event. Hear from professionals from Clinical Data Management, Clinical Science and Study Management, and Clinical Research Associate roles as they discuss their careers, the industry, and their experiences at Merck.
This session provided insights into the presenters experience with home health visits to-date and prompted site and investigator attendees to understand what works and doesn’t work for sites when offered home health options in trial protocols.